The efficacy of ceftazidime on bacterial otitis

Comparison of the efficacy of ceftazidime powder and Ciprosonate drop on treatment of external bacterial otitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130427013136N6

Enrollment

140

Registered

2020-02-13

Start date

2020-04-03

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial otitis externa. Unspecified otitis externa, unspecified ear

Interventions

Intervention 1: Intervention group: En Intervention group: : After suction, 30 mg ciprofloxacin powder (Exir pharmaceutical company, Borujerd, Iran) will use for once, by insufflation in to middle ear

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with bacterial otitis externa.

Exclusion criteria

Exclusion criteria: Patients who have fungal infections. Patients who have tympanic membranous perforation Patients with a history of ear surgery. Patients with defective ear canal.

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: En Severity of pain will determined by the patient's expression or pain index (Visual Analog Scale-VAS) which are between 0-10.;Swelling. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Severity of swelling will determine based on the examination of the ear by the physician.;Secretion. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Severity of secretion will determine based on the examination of the ear by the physician.	—

Measure

Time frame

Pain. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: En Severity of pain will determined by the patient's expression or pain index (Visual Analog Scale-VAS) which are between 0-10.;Swelling. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Severity of swelling will determine based on the examination of the ear by the physician.;Secretion. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Severity of secretion will determine based on the examination of the ear by the physician.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeid Mahdavi Omran

Babol University of Medical Sciences

s.mahdavi@mubabol.ac.ir+98 11 3219 9936

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026